venture
Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology
Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation
Forbion Secures Over €2 Billion in Largest Fundraising to Date, Supporting 30 Biotechs
Forbion, venture capital, life sciences, fundraising, biotechs, Forbion Growth Opportunities Fund III, Forbion Ventures Fund VII
Kurma Partners Secures €140M for Biofund IV, Aiming for €250M to Fuel European Healthcare Innovation
Kurma Partners, Biofund IV, Healthcare Innovation, Venture Capital, European Biotech, Healthcare Investment
Bain Capital Raises $3 Billion for Fourth Life Sciences Fund to Support Innovative Biotech Startups
Bain Capital, Life Sciences Fund, Biotech Startups, Venture Capital, Funding
Biotech IPO Market Sees Shifts in Funding and Investor Appetite
biotech IPOs, crossover funding, venture capital, clinical-stage assets, market correction, investor demand
venBio Secures $528M for Fifth Life Sciences Venture Capital Fund
venBio, life sciences, venture capital, Fund V, biotech investment
venBio Secures $528M for Fifth Life Sciences Venture Capital Fund
venBio, life sciences, venture capital, fund closing, biotech startups, biopharmaceuticals
Canaan Partners Raises Additional $100M for Biotech Investments, Adds Pfizer Vet Uwe Schoenbeck
Canaan Partners, Biotech investments, Venture capital, Pfizer, Uwe Schoenbeck, Biopharma, Healthcare, Venture partner
VC Firm Oversees NGM Bio’s $122M Series A Funding After Taking it Private
NGM Bio, The Column Group, Venture Capital, Biotech, Series A Funding
Flagship’s Noubar Afeyan on Uncertainty, AI, and the Future of Biotechnology
, Noubar Afeyan, Flagship Pioneering, Biotechnology, Artificial Intelligence (AI), Uncertainty, Innovation, Future of Biotech, Moderna, Venture Capital,